EverQuote (EVER)
(Delayed Data from NSDQ)
$22.31 USD
+0.88 (4.11%)
Updated Sep 9, 2024 04:00 PM ET
After-Market: $22.32 +0.01 (0.04%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$22.31 USD
+0.88 (4.11%)
Updated Sep 9, 2024 04:00 PM ET
After-Market: $22.32 +0.01 (0.04%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth B Momentum B VGM
Zacks News
EverQuote (EVER) Q1 Earnings Beat on Lower Operating Expenses
by Zacks Equity Research
EverQuote (EVER) expects total revenues of $70-$75 million for the second quarter of 2023.
EverQuote (EVER) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
EverQuote (EVER) delivered earnings and revenue surprises of 57.89% and 6.19%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Cigna (CI) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Cigna (CI) delivered earnings and revenue surprises of 3.44% and 2.11%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Saul Centers (BFS) Tops Q1 FFO Estimates
by Zacks Equity Research
Saul Centers (BFS) delivered FFO and revenue surprises of 5.33% and 0.95%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
MGIC Investment (MTG) Q1 Earnings Beat Estimates
by Zacks Equity Research
MGIC (MTG) delivered earnings and revenue surprises of 5.88% and 2.19%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
James River Group (JRVR) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
James River Group (JRVR) delivered earnings and revenue surprises of 7.69% and 9.63%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Should You Retain EverQuote (EVER) Stock in Your Portfolio?
by Zacks Equity Research
EverQuote (EVER) is poised to benefit from solid performance of automotive and other insurance marketplace verticals and higher consumer traffic.
EverQuote (EVER) Down 4.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
EverQuote (EVER) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MGIC's (MTG) Solid Insurance Written Aids, Expense Woes Stay
by Zacks Equity Research
Solid insurance in force, a decline in loss and claims payments, lower delinquency, better housing market fundamentals and a solid capital position poise MGIC Investment (MTG) well for growth.
Assurant (AIZ) Banks on Solid Segmental Growth Amid Cost Woes
by Zacks Equity Research
Assurant (AIZ) holds the potential to reap benefits driven by policies in force, favorable mobile loss experience and higher income on fixed maturity securities.
EverQuote (EVER) Q4 Earnings Beat on Lower Operating Expense
by Zacks Equity Research
EverQuote's (EVER) Q4 results witness lower revenues from the Automotive and Other insurance verticals due to the inability to raise premium rates quickly. Lower operating expenses act as an offset.
EverQuote (EVER) Reports Q4 Loss, Lags Revenue Estimates
by Zacks Equity Research
EverQuote (EVER) delivered earnings and revenue surprises of 3.70% and 2.09%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Goosehead Insurance (GSHD) Misses Q4 Earnings Estimates
by Zacks Equity Research
Goosehead (GSHD) delivered earnings and revenue surprises of -8.33% and 10.75%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
EverQuote (EVER) Soars 7.3%: Is Further Upside Left in the Stock?
by Zacks Equity Research
EverQuote (EVER) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
CNO Financial (CNO) Matches Q4 Earnings Estimates
by Zacks Equity Research
CNO (CNO) delivered earnings and revenue surprises of 0% and 6.71%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Here's Why Hold is an Apt Strategy for EverQuote (EVER) Now
by Zacks Equity Research
EverQuote (EVER) is poised to benefit from higher quote request volume and innovating advertiser products and a robust capital position.
EverQuote (EVER) Shows Fast-paced Momentum But Is Still a Bargain Stock
by Zacks Equity Research
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, EverQuote (EVER) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Radian (RDN) Down 6.3% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Radian (RDN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is EverQuote (EVER) Up 76.2% Since Last Earnings Report?
by Zacks Equity Research
EverQuote (EVER) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Should You Stay Invested in Willis Towers (WTW) Stock
by Zacks Equity Research
Segmental strength, solid capital position and favorable growth estimates make Willis Towers (WTW) stock worth retaining in one's portfolio.
Why Should You Stay Invested in Prudential (PRU) Stock?
by Zacks Equity Research
huge demand for retirement benefits products, recurring premium sales, greater scale, expanded product offerings and broader distribution capabilities, cost savings and a solid capital position well poise Prudential (PRU) for growth.
Reinsurance Group (RGA) Gains 28% YTD: More Upside Left?
by Zacks Equity Research
Better pricing and expanding business in the pension risk transfer market, solid in-force business ensuring predictable long-term earnings and effective capital deployment continue to drive Reinsurance Group (RGA).
Here's Why You Should Add EverQuote (EVER) to Your Kitty
by Zacks Equity Research
EverQuote (EVER) is poised to benefit from higher quote request volume and innovating advertiser products and a robust capital position.
Here Is Why Bargain Hunters Would Love Fast-paced Mover EverQuote (EVER)
by Zacks Equity Research
EverQuote (EVER) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Wall Street Analysts Think EverQuote (EVER) Could Surge 87%: Read This Before Placing a Bet
by Zacks Equity Research
The consensus price target hints at an 87.4% upside potential for EverQuote (EVER). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.